
Nudges Plus Machine Learning Triple Advanced Care Conversations
10.16.2020
Electronic nudges, triggered by a machine-learning algorithm that flags patients at greater mortality risk, increased conversations on end-of-life goals.
Our mission is to inspire, design, and advance solutions that improve the health and healthcare for patients with cancer. We do so by enhancing patient experience, improving patient outcomes, and increasing the efficiency and productivity of cancer care. We are passionate about catalyzing innovation with our partners.
Our Initiatives
10.16.2020
Electronic nudges, triggered by a machine-learning algorithm that flags patients at greater mortality risk, increased conversations on end-of-life goals.
08.05.2020
The National Cancer Institute will fund PC3I and other Penn partners for five years as part of the Cancer Moonshot Initiative.
06.22.2020
Chris Manz, MD, will receive a 2020 Young Investigator Award to study the effect of Medicare's Oncology Care model on disparities in patient access to new cancer therapies.
02.04.2021
In 2020, Penn Medicine delivered cancer treatments to nearly 1500 patients in the comfort of their own homes, propelled by PC3I's Cancer Care @ Home program.
10.22.2020
Americans take great cancer care for granted. The Covid-19 pandemic is putting this success at risk. In JAMA Oncology, we propose three solutions.
10.16.2020
PC3I and its partners launched Cancer Care @ Home in February 2020. One month later, the program had referred 39 patients. The next seven weeks saw a 700% increase in home infusion referrals.